1. Home
  2. AORT vs VCEL Comparison

AORT vs VCEL Comparison

Compare AORT & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$43.48

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$37.36

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AORT
VCEL
Founded
1984
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
1993
1997

Fundamental Metrics

Financial Performance
Metric
AORT
VCEL
Price
$43.48
$37.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$49.36
$57.50
AVG Volume (30 Days)
304.0K
586.8K
Earning Date
02-23-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
236.54
EPS
N/A
0.25
Revenue
$422,646,000.00
$258,716,999.00
Revenue This Year
$15.97
$17.86
Revenue Next Year
$10.96
$18.55
P/E Ratio
N/A
$151.65
Revenue Growth
9.81
14.05
52 Week Low
$21.97
$29.24
52 Week High
$48.25
$63.00

Technical Indicators

Market Signals
Indicator
AORT
VCEL
Relative Strength Index (RSI) 40.55 48.73
Support Level $41.82 $35.99
Resistance Level $45.99 $41.65
Average True Range (ATR) 1.38 1.75
MACD -0.28 -0.01
Stochastic Oscillator 33.07 32.12

Price Performance

Historical Comparison
AORT
VCEL

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: